Skip to content

Current ratio at other companies

Eli Lilly logo
Eli LillyLLY
1.5×+0.1×
Amgen logo
AmgenAMGN
1.3×+0.1×
Altimmune logo
AltimmuneALT
29.6×+13.7×
Viking Therapeutics logo
Viking TherapeuticsVKTX
5.7×-38.5×
Wave Life Sciences logo
Wave Life SciencesWVE
11.3×+8.3×
Prime Medicine logo
Prime MedicinePRME
3.8×-1.0×

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×

Where this comes from

Calculated from Vivani Medical’s reported figures.

Based on the most recent quarter.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's current ratio?
Vivani Medical (VANI) reported current ratio of 3.2× in Q1 2026.
How has Vivani Medical's current ratio changed year-over-year?
Vivani Medical's current ratio increased by 32.8% year-over-year, from 2.4× to 3.2×.
What is the long-term trend for Vivani Medical's current ratio?
Over 5 years (2020 to 2025), Vivani Medical's current ratio has grown at a 26.7% compound annual growth rate (CAGR), from 0.8× to 2.7×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.